HRP20050320A2 - Water-soluble polymer alkanals - Google Patents

Water-soluble polymer alkanals

Info

Publication number
HRP20050320A2
HRP20050320A2 HR20050320A HRP20050320A HRP20050320A2 HR P20050320 A2 HRP20050320 A2 HR P20050320A2 HR 20050320 A HR20050320 A HR 20050320A HR P20050320 A HRP20050320 A HR P20050320A HR P20050320 A2 HRP20050320 A2 HR P20050320A2
Authority
HR
Croatia
Prior art keywords
water
polymer alkanals
soluble polymer
alkanals
present
Prior art date
Application number
HR20050320A
Other languages
English (en)
Inventor
Kozlowski Antoni
Original Assignee
Nektar Therapeutics Al
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al filed Critical Nektar Therapeutics Al
Publication of HRP20050320A2 publication Critical patent/HRP20050320A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/198—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

Ovaj izum je usmjeren na derivate alkanala u voditopljivih polimera, poput poli(etilen glikola), njegovih odgovarajućih hidrata i acetala, i na postupke za pripravu i upotrebu takvih polimer alkanala. Polimer alkanali ovog izuma pripravljeni su s visokom čistoćom i pokazuju stabilnost prilikom skladištenja.
HR20050320A 2002-09-09 2005-04-07 Water-soluble polymer alkanals HRP20050320A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40925102P 2002-09-09 2002-09-09
US45658003P 2003-03-19 2003-03-19
PCT/US2003/028221 WO2004022630A2 (en) 2002-09-09 2003-09-09 Water-soluble polymer alkanals

Publications (1)

Publication Number Publication Date
HRP20050320A2 true HRP20050320A2 (en) 2006-12-31

Family

ID=31981629

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20050319A HRP20050319A2 (en) 2002-09-09 2005-04-07 Water-soluble polymer alkanals
HR20050320A HRP20050320A2 (en) 2002-09-09 2005-04-07 Water-soluble polymer alkanals

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HR20050319A HRP20050319A2 (en) 2002-09-09 2005-04-07 Water-soluble polymer alkanals

Country Status (22)

Country Link
US (5) US7157546B2 (hr)
EP (1) EP1546235B1 (hr)
JP (2) JP4764630B2 (hr)
KR (2) KR100974843B1 (hr)
AP (2) AP2005003249A0 (hr)
AU (1) AU2003270454B2 (hr)
BR (1) BR0314172A (hr)
CA (1) CA2498167C (hr)
EA (1) EA200500475A1 (hr)
EC (1) ECSP055654A (hr)
ES (1) ES2897470T3 (hr)
GE (1) GEP20074193B (hr)
HR (2) HRP20050319A2 (hr)
IS (1) IS7789A (hr)
MA (1) MA27401A1 (hr)
MX (1) MXPA05002620A (hr)
NO (2) NO20051078L (hr)
NZ (2) NZ540490A (hr)
PL (1) PL375883A1 (hr)
RS (2) RS20050202A (hr)
UA (1) UA80838C2 (hr)
WO (1) WO2004022630A2 (hr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053150B2 (en) * 2000-12-18 2006-05-30 Nektar Therapeutics Al, Corporation Segmented polymers and their conjugates
HUE028163T2 (en) * 2002-01-18 2016-11-28 Biogen Ma Inc Polyalkylene polymer compounds and their use
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
KR100974843B1 (ko) * 2002-09-09 2010-08-11 넥타르 테라퓨틱스 수용성 중합체 알카날
JP2006516534A (ja) * 2002-09-11 2006-07-06 フレセニウス・カビ・ドイッチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｈａｓ化ポリペプチド、特にｈａｓ化エリスロポエチン
NZ541124A (en) * 2002-12-26 2008-08-29 Mountain View Pharmaceuticals Polymer conjugates of interferon-beta with enhanced biological potency
GEP20084487B (en) * 2002-12-26 2008-09-25 Mountain View Pharmaceuticals Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof
ES2911435T3 (es) * 2003-02-26 2022-05-19 Nektar Therapeutics Conjugados de polímero-resto de Factor VIII
US7947261B2 (en) 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
US20080274948A1 (en) * 2003-08-08 2008-11-06 Fresenius Kabi Deutschland Gmbh Conjugates of Hydroxyalkyl Starch and G-Csf
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
EP2279752A3 (en) * 2004-03-11 2011-08-24 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation
EP2336192A1 (en) * 2004-03-11 2011-06-22 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
CA2558583C (en) 2004-03-15 2013-07-09 Nektar Therapeutics Al, Corporation Polymer-based compositions and conjugates of hiv entry inhibitors
MXPA06010764A (es) * 2004-03-23 2006-12-15 Amgen Inc Metodos y composiciones de proteinas quimicamente modificadas.
JP2008506704A (ja) * 2004-07-16 2008-03-06 ネクター セラピューティクス アラバマ，コーポレイション Ｇｍ−ｃｓｆ成分およびポリマーの複合体
AP2007003919A0 (en) * 2004-08-31 2007-02-28 Pharmacia & Upjohn Co Llc Glycerol branched polyethylene glycol human growthhormone conjugates, process for their prepation a nd methods of use thereof
JP4920593B2 (ja) * 2004-10-25 2012-04-18 インテザイン テクノロジーズ， インコーポレイテッド ヘテロ二官能性ポリ（エチレングリコール）およびそれらの使用
WO2006094810A2 (en) * 2005-03-11 2006-09-14 Fresenius Kabi Deutschland Gmbh Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
WO2007010552A2 (en) * 2005-03-17 2007-01-25 Serum Institute Of India Limited N- terminal peg conjugate of erythropoietin
US20060233740A1 (en) * 2005-03-23 2006-10-19 Bossard Mary J Conjugates of an hGH moiety and a polymer
EP1762250A1 (en) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
US8293869B2 (en) 2005-12-16 2012-10-23 Nektar Therapeutics Polymer conjugates of GLP-1
EP1834963A1 (en) * 2006-03-13 2007-09-19 Siegfried Ltd. Di-polymer protein conjugates and processes for their preparation
EP2010477A4 (en) * 2006-04-27 2012-05-30 Intezyne Technologies Inc POLY (ETHYLENE GLYCOL) CONTAINING CHEMICALLY DISPARATE ENDOGROUP
CL2008002399A1 (es) 2007-08-16 2009-01-02 Pharmaessentia Corp Conjugado sustancialmente puro que posee una porcion polimerica, una porcion proteica (interferon alfa 2b) y un ligante alifatico de 1 a 10 atomos de carbono, util en el tratamiento de las hepatitis b o c.
EP2070951A1 (en) * 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Method for producing a hydroxyalkyl starch derivatives with two linkers
EP2070950A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkyl starch derivatives and process for their preparation
WO2009099670A2 (en) * 2008-02-08 2009-08-13 Nektar Therapeutics Al, Corporation Oligomer-cannabinoid conjugates
KR100967833B1 (ko) * 2008-05-20 2010-07-05 아이디비켐(주) 고순도의 폴리에틸렌글리콜 알데하이드 유도체의 제조방법
AR072850A1 (es) * 2008-07-31 2010-09-22 Pharmaessentia Corp Conjugados peptido-polimero
US8492503B2 (en) 2008-09-11 2013-07-23 Nektar Therapeutics Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
US20110171312A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Modified therapeutic peptides, methods of their preparation and use
GB0823309D0 (en) * 2008-12-19 2009-01-28 Univ Bath Functionalising reagents and their uses
CN105601728B (zh) 2009-07-14 2020-01-10 斯克里普斯研究所 间充质干细胞分化
JP2013533217A (ja) 2010-05-17 2013-08-22 セビックス・インコーポレイテッド Ｐｅｇ化ｃ−ペプチド
RU2447083C1 (ru) * 2010-07-20 2012-04-10 Закрытое Акционерное Общество "Биокад" НОВЫЙ ФУНКЦИОНАЛЬНО АКТИВНЫЙ ВЫСОКООЧИЩЕННЫЙ СТАБИЛЬНЫЙ КОНЪЮГАТ ИНТЕРФЕРОНА α С ПОЛИЭТИЛЕНГЛИКОЛЕМ, ПРЕДСТАВЛЕННЫЙ ОДНИМ ПОЗИЦИОННЫМ ИЗОМЕРОМ ПЭГ-NαH-ИФН, С УМЕНЬШЕННОЙ ИММУНОГЕННОСТЬЮ, С ПРОЛОНГИРОВАННЫМ БИОЛОГИЧЕСКИМ ДЕЙСТВИЕМ, ПРИГОДНЫЙ ДЛЯ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ, И ИММУНОБИОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ
WO2012054822A1 (en) 2010-10-22 2012-04-26 Nektar Therapeutics Pharmacologically active polymer-glp-1 conjugates
CA3144697A1 (en) * 2010-11-12 2012-05-18 Nektar Therapeutics Conjugates of an il-2 moiety and a polymer
EP2540325B1 (en) * 2011-06-27 2016-08-10 Greatbatch Ltd. Peptide based antimicrobial coating
EP2592103A1 (en) * 2011-11-08 2013-05-15 Adriacell S.p.A. Polymer aldehyde derivatives
JP5999659B2 (ja) * 2011-12-14 2016-09-28 国立大学法人 筑波大学 新規分岐ポリエチレングリコール及びその用途
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
UY35368A (es) 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
JP6106104B2 (ja) 2014-01-16 2017-03-29 信越化学工業株式会社 末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法
JP6106103B2 (ja) * 2014-01-16 2017-03-29 信越化学工業株式会社 末端にアミノ基を有する狭分散ポリアルキレングリコール誘導体の製造方法、並びにこれに用いる新規なアセタール基含有アルコール化合物及びそのアルカリ金属塩
GB201419108D0 (en) 2014-10-27 2014-12-10 Glythera Ltd Materials and methods relating to linkers for use in antibody drug conjugates
MX2017005244A (es) 2014-11-06 2017-08-18 Pharmaessentia Corp Regimen de dosificacion para interferon pegilado.
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002531A (en) * 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
JPS5695142A (en) * 1979-12-28 1981-08-01 T Hasegawa Co Ltd Preparation of aliphatic aldehyde
US5037969A (en) 1986-07-03 1991-08-06 Takeda Chemical Industries, Ltd. Glycosyl derivatives and use thereof
JPS63152393A (ja) * 1986-07-03 1988-06-24 Takeda Chem Ind Ltd グリコシル誘導体
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
WO1990005534A1 (en) 1988-11-23 1990-05-31 Genentech, Inc. Polypeptide derivatives
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
JPH06233816A (ja) 1993-02-12 1994-08-23 Toyobo Co Ltd 血液浄化吸着材
US5840900A (en) 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5627662A (en) 1994-04-28 1997-05-06 Xerox Corporation Digital imaging system using two-dimensional input sensor array and output light valve
FR2724459B1 (fr) 1994-09-14 1997-05-09 Univ Compiegne Tech Electrophorese capillaire d'affinite, matrice d'affinite pour la mise en oeuvre de cette electrophorese et son procede de fabrication
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5990237A (en) 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
JPH11322916A (ja) 1998-05-11 1999-11-26 Kazunori Kataoka ビオチン残基を片末端に有するヘテロテレケリツクポリマー
US6420555B1 (en) * 1998-06-16 2002-07-16 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
US6465694B1 (en) 1998-10-26 2002-10-15 University Of Utah Research Foundation Method for preparation of polyethylene glycol aldehyde derivatives
AU2346900A (en) 1998-11-30 2000-06-19 Eli Lilly And Company Erythropoietic compounds
JP2000303090A (ja) * 1999-04-20 2000-10-31 T Hasegawa Co Ltd 香料組成物
DK1259562T3 (da) 1999-12-22 2006-04-18 Nektar Therapeutics Al Corp Sterisk hindrede derivater af vandoplöselige polymerer
TW593427B (en) 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
AU2002352524B2 (en) 2001-11-07 2007-10-04 Nektar Therapeutics Branched polymers and their conjugates
KR20070072924A (ko) 2001-11-20 2007-07-06 파마시아 코포레이션 화학적으로 개질된 인간 성장 호르몬 콘쥬게이트
US20030171285A1 (en) 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
US6916962B2 (en) 2001-12-11 2005-07-12 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
US6956135B2 (en) 2001-12-11 2005-10-18 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
AU2002357806A1 (en) * 2001-12-11 2003-06-23 Sun Bio, Inc. Novel monofunctional polyethylene glycol aldehydes
HUE028163T2 (en) 2002-01-18 2016-11-28 Biogen Ma Inc Polyalkylene polymer compounds and their use
KR100998381B1 (ko) * 2002-04-26 2010-12-03 다이쿄 니시카와 가부시키가이샤 흡음체, 흡음 구조체, 흡음체의 제조 방법 및 흡음 구조체의 제조 방법
MXPA05000799A (es) 2002-07-24 2005-04-19 Hoffmann La Roche Derivados de aldehidos de polietilenglicol.
KR100974843B1 (ko) * 2002-09-09 2010-08-11 넥타르 테라퓨틱스 수용성 중합체 알카날
US20040142870A1 (en) 2002-11-20 2004-07-22 Finn Rory F. N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
TWI281864B (en) 2002-11-20 2007-06-01 Pharmacia Corp N-terminally monopegylated human growth hormone conjugates and process for their preparation
US6961962B1 (en) 2004-09-09 2005-11-08 Morning Pride Manufacturing, L.L.C. Combined closure and liner zippers employing common zipper tapes and protective garment employing said combined zippers
JP5084245B2 (ja) 2006-06-07 2012-11-28 関西ペイント株式会社 澱粉系塗料組成物

Also Published As

Publication number Publication date
US7157546B2 (en) 2007-01-02
ECSP055654A (es) 2005-05-30
US20040116649A1 (en) 2004-06-17
JP2005538224A (ja) 2005-12-15
CA2498167A1 (en) 2004-03-18
NO20051077L (no) 2005-04-08
CA2498167C (en) 2012-03-20
US20090234070A1 (en) 2009-09-17
RS20050203A (en) 2007-08-03
MA27401A1 (fr) 2005-06-01
EP1546235B1 (en) 2021-10-20
US20120065429A1 (en) 2012-03-15
US7511094B2 (en) 2009-03-31
JP4764630B2 (ja) 2011-09-07
US7838595B2 (en) 2010-11-23
WO2004022630A3 (en) 2004-04-15
NO20051078L (no) 2005-04-08
AU2003270454A1 (en) 2004-03-29
GEP20074193B (en) 2007-09-10
HRP20050319A2 (en) 2006-12-31
US8076412B2 (en) 2011-12-13
AP2005003249A0 (en) 2005-03-31
IS7789A (is) 2005-04-08
EA200500475A1 (ru) 2005-10-27
JP2005350470A (ja) 2005-12-22
AU2003270454B2 (en) 2010-05-20
KR20050057281A (ko) 2005-06-16
UA80838C2 (en) 2007-11-12
NZ538624A (en) 2007-01-26
US20110034737A1 (en) 2011-02-10
MXPA05002620A (es) 2005-05-05
WO2004022630A2 (en) 2004-03-18
US20060194940A1 (en) 2006-08-31
RS20050202A (en) 2007-08-03
BR0314172A (pt) 2005-07-26
US8853325B2 (en) 2014-10-07
NZ540490A (en) 2007-10-26
KR20050093856A (ko) 2005-09-23
KR100974843B1 (ko) 2010-08-11
ES2897470T3 (es) 2022-03-01
EP1546235A2 (en) 2005-06-29
PL375883A1 (en) 2005-12-12
AP2005003246A0 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
HRP20050320A2 (en) Water-soluble polymer alkanals
EA202092025A1 (ru) Конъюгаты компонента il-2 и полимера
ATE491475T1 (de) Konjugate enthaltend gm-csf und ein polymer
BR0314831A (pt) Conjugados de polìmeros com antigenicidade diminuìda, seus métodos de preparação e usos
GB2442374A (en) Crosslinkable polymer compositions
BR0307962A (pt) Preparação cosmética
CY1110169T1 (el) Μεθοδος παρασκευης πολυμερων με χαρακτηριστικες δραστικες ομαδες απο πολυμερεις αλκοολες
AR035661A1 (es) Composicion de copolimero, metodo para su uso y proceso de preparacion
BR112013000386A2 (pt) combinação de polímero acrílico, composição, e, métodos para mascarar uma combinação polimérica com base em acrílico, e para espessar uma composição aquosa
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
CY1119038T1 (el) Φαρμακευτικο εναιωρημα
MXPA06000921A (es) Derivados de benzamidazoles como inhibidores de mek.
ECSP034765A (es) Derivados de bipiperidinilo y su uso como inhibidores de receptores de quimiocina
ATE490986T1 (de) Polymer, vernetztes polymer, zusammensetzung für ein feststoffpolymer-elektrolyt, feststoffpolymer-elektrolyt und klebstoffzusammensetzung
DE60334536D1 (de) Furylverbindungen
TW200720356A (en) Ether composition and solution composition
WO2013030840A3 (en) Adhesive biopolymers and uses thereof
WO2006102659A3 (en) CONJUGATES OF AN hGH MOIETY AND A POLYMER
WO2007030623A3 (en) Bi-modal hyaluronate solution
DE60037392D1 (de) Fester elektrolyt aus vernetztem polymer und dessen verwendung
DE602004022996D1 (de) Kosmetische zusammensetzung mit einem ampholyt-copolymer
TNSN05055A1 (en) Water-soluble polymer alkanals
BR0314781A (pt) Composição de polìmero e formas de dosagem compreendendo a mesma
TNSN05056A1 (en) Water-soluble polymer alkanals
AU2018332214A8 (en) Modified nucleoside phosphoramidites

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20070905

Year of fee payment: 5

OBST Application withdrawn